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Abstract 
Background. Laryngeal cancer management should pursue function-sparing therapeutic 
options. Even though demolitive surgery provides better control of disease at intermediate-
advanced stages when compared to chemoradiotherapy, it does not preserve laryngeal 
function. Supratracheal partial laryngectomy (STPL) has been described as a function-
sparing surgical technique for laryngeal cancer with sub-glottic extension. 
Methods. In this retrospective study, we analyzed the clinical outcomes of 115 patients 
who underwent STPL. 
Results. At 5 years: overall survival (OS), disease-free survival (DFS) and loco-regional 
control (LRC) rates were 78.9%, 68.5% and 69.6%, respectively; DFS and LRC 
prevalences were greatly affected by pT4a classification (49.0% and 51.4%, respectively); 
laryngeal function preservation (LFP) was maintained in 78.3% of patients despite being 
affected by pT4a classification (59.3%) and age ≥65 (64.6%). 
Conclusions. For cases with glottic tumors and with sub-glottic extension, the choice of 
STPL vs chemoradiotherapy can be considered to be effective in terms of prognostic and  
functional results. 
Introduction 
 
Laryngeal squamous cell carcinoma (LSCC) represents 2% to 5% of all diagnosed tumors 
worldwide with a peak incidence in men aged between 55 and 65 years.1 Therapeutic 
approaches developed in the twentieth century have significantly improved overall survival 
from this type of cancer, however, poor prognosis and loss of functionality of the larynx still 
characterize the disease in its advanced stage.2-4 Treatment includes surgery alone or in 
combination with chemo- and/or radiotherapy, and management of laryngeal cancer varies 
depending on localization and staging at diagnosis. Early stages (I and II) are treated with 
unimodal therapy, which can include surgery or radiotherapy, while for the advanced 
stages (III and IV), chemo-radiotherapy and demolitive surgery are considered to be the 
gold standard therapeutic approach.5-7 A third alternative, though not fully accepted 
worldwide, is represented by function-sparing surgical protocols with open partial 
laryngectomy. Despite encouraging oncological results, the main criticisms of this 
approach are the criteria for patient selection and functional results, the latter being not 
easily repeatable.8-11 
To preserve laryngeal function surgically in intermediate and advanced stages, different 
types of open partial laryngectomy have been proposed beginning with the first 
supratracheal open partial laryngectomy (STPL) described by Italo Serafini in 1972.12 In 
2006, our group reported a modified functional version, in which at least one functioning 
cricoarytenoid unit was spared (i.e. half of the posterior cricoid plate, with the 
corresponding arytenoid and the intact inferior laryngeal nerve on the same side).13 
Nowadays, STPL is based on resection of the whole glottic and subglottic sites and of the 
thyroid cartilage, sparing both or at least one functioning cricoarytenoid unit. Inferiorly, the 
limit of resection encompasses the cricoid ring sparing the first tracheal ring. The various 
types of STPLs, also identified by the type of laryngeal resynthesis as tracheo-hyoid-
epiglottopexy (STPL-THEP) or tracheo-hyoid-pexy (STPL-THP), differ in the amount of 
supraglottis resected and in the lateral extent, if any, to include one cricoarytenoid unit. 
Extending the inferior limit of resection to include a large part of the cricoid cartilage, 
STPLs expanded the indications with respect to open partial supracricoid laryngectomies 
(SCPL).14, 15 Some “problematic” glottic cT3 (i.e. sub-glottic extension and cricoarytenoid 
joint invasion) and some supraglottic cT3 (i.e. large transglottic extension) result, hence 
are manageable with STPLs; these interventions have shown promising oncological and 
functional results.13 
In this study, we present a multicentric retrospective outcome analysis of 115 patients with 
supraglottic/glottic LSCC managed by STPL-THEP or STPL-THP over a 10-year period, 
during which organ-preservation protocols with chemoradiotherapy or total laryngectomy 
were applied as conventional therapeutic options for these types of locally advanced 
tumor.5, 7, 16 
Materials and methods 
Patients 
All patients were from the Hospital of Vittorio Veneto, Treviso or the Martini Hospital of 
Turin. Selection was based on the superficial and depth extent of the tumor. During the 3 
weeks preceding surgery, all patients underwent: flexible videolaryngoscopy; 
intraoperative rigid endoscopy with 0°/angled telescopes and biopsy during 
microlaryngoscopy; laryngeal and neck CT-scan or MRI; bronchoscopy and 
esophagoscopy to rule out synchronous tumors; chest X-ray or CT-scan to exclude lung 
tumors or distant metastases; assessment of bronchopulmonary function and of 
comorbidities for at-risk patients; and nutritional evaluation. 
Inclusion criteria were histological diagnosis of glottic or supraglottic LSCC, with Karnofsky 
index17 higher than 80. 
Exclusion criteria were severe diabetes mellitus, severe bronchopulmonary chronic 
obstructive disease and severe cardiac disease. Advanced age, an important cut-off for 
relative surgical indication, has not been considered, in itself, as an exclusion criterion.18 
 
Surgery 
After informed consent had been obtained, 120 patients were selected to undergo STPLs 
from 1 January 2002 to 31 December 2011. Five cases were excluded from analysis due 
to the presence of a different pathology: four cases of low-grade chondrosarcoma and one 
case of muco-epidermoid carcinoma. 
Thirty-six patients (31.3%) included in the present analysis were treated previously for 
laryngeal carcinoma by chemo-radiation therapy (12/36, 33.3%), CO2 trans-oral laser 
surgery (16/36, 44.4%), open partial laryngectomy (4/36, 11.1%) or cordectomy (4/36, 
11.1%). 
The tumors were glottic in 103 patients and supraglottic in 12 patients. The vocal fold 
mobility was: 22 cases with normal or impaired vocal cord mobility (8 supraglottic pT4a 
and 14 glottic pT2), 44 cases with fixed vocal cord and mobile cricoarytenoid joint (1 
supraglottic pT3, 3 supraglottic pT4a, 5 transglottic pT3, 16 glottic pT3, and 19 glottic 
pT4a) and 49 cases with fixed vocal cord and cricoarytenoid joint (29 glottic-subglottic pT3, 
19 glottic pT4a and 1 transglottic pT3). 
Resections were classified as follows: STPL-THEP=10 (8.7%), STPL-THEP+A=95 
(82.6%), STPL-THP=4 (3.5%), STPL-THP+A=6 (5.2%), where “+A” represents the 
removal of one cricoarytenoid unit. 
The adopted indications for STPL interventions were: A) glottic T2 tumors with anterior 
subglottic extension, spreading downward above the conus elasticus and reaching the 
cricoid ring; B) glottic-subglottic T3 tumors spreading within the paraglottic space and 
controlled by the conus elasticus medially and the perichondrium of the thyroid cartilage 
laterally (tumor growth is directed downward and laterally, sometimes infiltrating the 
inferior edge of thyroid cartilage or escaping the larynx between the thyroid and cricoid 
cartilages through the cricoarytenoid membrane: the so-called early glottic pT4a). Typical 
clinical features are fixed vocal cord, fixed arytenoid and subglottic swelling; C) transglottic 
T3 tumors spreading superiorly into the deep tissue of the ventricular band under the 
quadrangular membrane and progressing into the subglottic area, where they invade the 
internal lamina or the inferior edge of the thyroid cartilage or the superior edge of the 
cricoid; D) T3 glottic tumors with paraglottic space invasion and surface extension toward 
the posterior commissure (a typical radiological feature is the initial sclerosis of the cricoid 
hemiplate); E) supraglottic T3 of the infrahyoid epiglottis spreading laterally to the petiolus 
and into the preepiglottic space encompassing the anterior commissure toward the cricoid 
ring (often escaping the larynx through the thyroid cartilage or cricoarytenoid membrane 
with fixation or impaired mobility of the anterior vocal cords but without affecting the 
arytenoid mobility: early supraglottic pT4a). 
The contraindications related to loco-regional extension were: A) glottic-subglottic T3 
tumors with massive invasion of the paraglottic space reaching the posterior cricoarytenoid 
muscle and the pyriform sinus submucosa; B) gross glottic-subglottic T4a with massive 
cricoid invasion or reaching the first tracheal ring; C) lymph nodes staged N3. 
In all patients, resection margins were examined intraoperatively with frozen sections: 
when positive, the resection was expanded until the margins were negative. The margins 
of the surgical specimen were always checked again upon definitive pathology. Neck 
dissection (ND), graded according to the AAO-HNS classification,19 was performed in 75 
patients (65.2%), and was monolateral in 42 (56%) and bilateral in 33 (44%) cases. ND 
was elective (ND levels II-IV) in 70 cN0 patients (60.8%), and curative (ND levels II-V + 
Internal Jugular Vein in one case) in 5 cN>0 patients (11.1%). In 55 patients, whole level 
VI or unilateral paratracheal lymph node clearance was added. No ND was performed in 
an additional 40 patients (34.8%) with early disease, cN0 disease or in previously treated 
neck. 
 
Postoperative care and adjuvant treatments 
All patients were monitored for early complications (local and general) and late sequelae. 
Patients underwent the same rehabilitation protocol, apart from those with serious early 
complications. 
The postoperative protocol consisted of: i) days 1–4: insertion of an uncuffed tracheal 
cannula and beginning of phonation; ii) days 4–6: during daytime, intermittent occlusion of 
the tracheostomy with saline-soaked gauze and starting of feeding without the tracheal 
cannula in position; iii) day 6 onwards, the nasogastric tube (NGT) was removed as soon 
as a good level of swallowing of both solids and liquids was achieved. Grading of post-
operative aspiration was performed in accordance with Pearson’s scale.4 On the basis of 
pathological findings (pN+ and/or ECS, large extralaryngeal extension), 31 patients 
(26.9%) were subjected to adjuvant radiotherapy. The indications for adjuvant therapy 
were: 7 N+ (5 level VI N+ and 2 N2b) and 24 cases with gross extralaryngeal extension (8 
supraglottic pT4a and 16 glottic pT4a). 
A large volume encompassing the primary site and all draining lymph nodes was irradiated 
with a dose of up to 54 Gy/2 Gy. Regions at higher risk for malignant dissemination 
received a 12-Gy boost (total 66 Gy/2 Gy – range 62–68 Gy). Six of 31 patients also 
received 100 mg/m2 cisplatin on days 1, 22, and 43 of the course of radiotherapy.20, 21 
 
Larynx functional assessment 
During the five post-operative years, Pearson’s Scale evaluation was repeated and larynx 
functional status was evaluated by the Performance Status Scale.22 
 
Statistical methods 
Overall survival (OS), disease-free survival (DFS), loco-regional control (LRC) and 
laryngeal function preservation (LFP) were estimated at 3 and 5 years using Kaplan–Meier 
curves. The end points considered were obtained as the length of time from the date of 
diagnosis to: OS) the date of death; DFS) the date of the first recurrence; LRC) the date of 
the first loco-regional recurrence; LFP) the date of total laryngectomy or presence of 
tracheostomy, NGT, gastrostomy feeding, or non-intelligible voice. At the end of the study, 
the dates of last consultation for patients still alive or free from recurrences or without any 
laryngeal impairment were used for type-I censoring in the corresponding end point. 
pT classification, clinical history of previous treatment and age were evaluated for their 
correlation with prevalence of OS, DFS, LRC and LFP by log-rank test. The corresponding 
incidences were evaluated by χ2-tests. All analyses were carried out with GraphPad Prism 
version 5.00 (GraphPad Software, San Diego, CA, USA), with P<0.05 as the significant 
cut-off. 
RESULTS 
Patients 
One hundred and twenty patients undergoing STPLs were initially included in this study. 
After excluding those treated for non-SCC, a cohort of 115 patients was considered (Table 
1). Patients were followed for a mean period of 3.37 years. Current or former smokers 
made up 91% of the cohort. 
 
Pathology 
All patients had a biopsy-proven LSCC staged between II and IVa according to the 2002 
TNM classification system23 (Table 1). Furthermore, pathology reports indicated close 
margins (<2 mm) in 11 cases (9.6%) and in any case were found positive margins at the 
definitive histopathologic examination. One hundred and ten patients (95.6%) had been 
classified as cN0 by palpation and neck CT-scan or MRI. Overall, lymph node metastases 
were detected in 7/115 patients (6.1%), of whom 3 (2.6%) had multiple metastases. 
 
Disease control and survival 
The 3-year OS, DFS and LRC were 84.6%, 72.3% and 73.3%, respectively. At 5 years, 
they were 78.9%, 68.5% and 69.6%, respectively (Figure 1). 
 
Correlation of pT category, previous treatment and age to overall survival, disease-free 
survival and loco-regional control 
Locally intermediate/advanced laryngeal carcinomas are a heterogeneous group of lesions 
in terms of superficial and depth extent. As a consequence, they differ greatly in surgical 
indications and prognosis. Therefore, the analyses were conducted on the basis of 
pathological staging in order to obtain homogeneous prognostic data. By stratifying the 
chart data, we evaluated whether they could affect the OS, DFS, and LRC in terms of 
prevalence (Figure 2). We found that none of the factors affected patients’ OS at 5 years. 
Indeed, the 5-year OS of pT2 tumors was 75.0%, while those of pT3 and pT4a SCC were 
82.2% and 73.7%, respectively. The 5-year OS of previously treated patients was very 
similar to that of untreated patients (80.8% and 79.0%, respectively). There was a small 
but not statistically significant difference in OS between older and younger patients (70.8% 
and 82.0%, respectively). 
DFS and LRC prevalence at 5 years were greatly affected by local staging. Despite the 
fact that pT2 and pT3 carcinomas displayed comparable DFS prevalences of 85.7% and 
82.9%, the 5-year DFS of pT4a tumors was only 49.0% (P<0.01). Likewise, the prevalence 
of 5-year LRC was comparable between pT2 and pT3 tumors (85.7% and 82.9%, 
respectively), but significantly lower for pT4a SCC (51.4%, P<0.05). On the other hand, 
the clinical history of previous treatment did not affect the 5-year prevalence of DFS and 
LRC. In fact, the prevalences of DFS and LRC were both 65.1% in pre-treated patients, 
whereas they were 70.1% and 71.7%, respectively, in patients undergoing STPL as 
primary surgery. Similarly, age also did not correlate with DFS and LRC: older patients had 
a prevalence of 62.4% for DFS and 65.6% for LRC, while younger ones had a prevalence 
of 71.8% for both. 
Finally, in terms of incidence, the overall analyses of the end points considered are 
reported in Table 2. 
 
Patterns of failure 
Loco-regional recurrences affected 28 patients within 5 years from surgery. According to 
the site of pathology, they were sub-grouped as 20 local (71.4%) and 8 regional (28.6%) 
recurrences. 
Local recurrences were observed in 14 (17.7%) untreated and 6 (16.7%) pre-treated 
patients. Among them, two had subglottic extension and inclusion of a cricoarytenoid joint, 
one had surface extension as far as the inferior edge of the cricoid ring, 14 had 
extralaryngeal extension (9 anterior, 5 posterior) and three showed surface extension 
toward the posterior commissure. 
Inside the larynx, the typical subsites of local failure were the mucosa at the passage 
between the remnant larynx and trachea or the mucosa at the level of the posterior 
commissure, as well as outside the larynx at the level of the outer surface of the remnant 
larynx (probably one of these options: in transit metastasis, lymph node metastases at the 
level of Berry’s ligament, direct invasion of the thyroid gland). The most frequent site of 
close margins was the posterior commissure mucosa. 
In all patients with local recurrence, salvage therapy included total laryngectomy and 
adjuvant radiation therapy and/or chemotherapy in 16 patients, and laser surgery in four 
cases. One patient was lost at follow-up, five patients died of laryngeal cancer from 
progression of disease (average 14.0 months, range 7.4–34.1 months), three patients died 
of other disease, while at the last follow-up, three patients were alive with the disease and 
eight patients were alive and disease-free; overall local control after salvage therapy was 
achieved in eight of 20 patients (40.0%) and at 3 years, the local control rate was 70.0%. 
Recurrence in the neck was observed in eight cases, six of whom were previously 
classified as cN0 and two as cN>0 patients. At the time of primary resection, five of these 
eight received bilateral neck dissection, and five out of eight recurrences were observed at 
the VI level. Five recurrences in the neck were treated with surgery and adjuvant radiation 
therapy and/or chemotherapy, three recurrences with chemotherapy, one of whom also 
received radiation therapy; three patients died due to regional recurrences (range 3.8–21.0 
months, mean 13.7 months), one patient died of other disease while at the last follow-up, 
one patient was alive with disease and three patients were alive and disease-free. 
 
Postoperative course and morbidity 
Overall acute complications during hospitalization occurred in seven out 115 patients 
(6.1%) and there were no perioperative deaths. The mean hospitalization time for patients 
with acute complications was 38 +/- 6 days, which was significantly longer than that for 
patients without acute complications (24 +/- 5 days; P<0.01). Late sequelae following 
discharge were observed in 28 out of 115 cases (24.4%) (Table 3). All were successfully 
treated with trans-oral CO2 laser surgery (23/28, 82.1%), injective laryngoplasty using Vox-
implants which successfully treated dysphagia (2/28, 7.1%), or total laryngectomy (1/28, 
3.6%). 
 
Laryngeal function preservation 
At 5 years, LFP was maintained in 90 out 115 (78.3%) patients. In addition, we evaluated 
whether LFP could be affected by local staging, presence of previous treatment or age ≥65 
years (Figure 3). Patients affected by advanced pT or characterized by older age were 
statistically significantly more prone to lose laryngeal function (P<0.01) with respect to 
intermediate pT or younger patients. In fact, functionality was maintained in all pT2 and in 
91.2% of pT3 patients, but only in 59.3% of pT4a patients. Moreover, LFP was maintained 
in 84.2% of patients <65 years old and in only 64.6% of patients ≥65 years. On the other 
hand, no statistically significant differences were observed when stratifying patients for 
previous treatment: laryngeal function was preserved in 79.0% and 75.8% of untreated 
and treated patients, respectively. 
After the first post-operative month, normal swallowing (Pearson’s scale Grade 0) was 
achieved in 66 patients (57.4%), Grade I and II were observed in 25 (21.7%) and 20 
(17.4%) patients, respectively, while aspiration pneumonia (AP) (Pearson’s Grade III) was 
recorded in four patients (3.5%). After the second year, a satisfactory degree of laryngeal 
function (i.e. List’s scale: eating in public > 50, understandability of speech > 50, Normalcy 
of diet > 70) was achieved in 92 out of 115 patients without local disease (80.0%). Out of 
the 92 patients evaluated for subjective aspiration by the Pearson’s scale, 23 (25.0%) had 
no aspiration (Grade 0), 46 (50.0%) had occasional cough without clinical problems 
(Grade I), and 20 (21.7%) had constant cough that worsened during meals (Grade II). 
Three patients (3.7%) had frequent pulmonary complications (Grade III). Nearly all patients 
(112/115; 97.4%) had had the NGT or gastrostomy removed. The NGT remained in place 
for an average of 21.5 days (range 12–161 days). 
Overall, AP was observed in 11/115 cases (9.6%), four cases during hospitalization and 
seven cases during follow-up. Due to intense dysphagia and AP episodes, a temporary 
gastrostomy was required in eight patients (7.0%); for five of them, it was removed within 
the first post-operative year. Only in three cases was the gastrostomy maintained due to 
repeated episodes of AP and severe dysphagia for liquids. In two cases, total 
laryngectomy was proposed for persistent aspiration: one patient accepted while the 
second refused, preferring to keep the gastrostomy and maintain voice. The third patient 
was subjected to the endoscopic procedure of injective laryngoplasty using Vox implant, 
which successfully resolved the dysphagia, allowing gastrostomy removal. 
The mean time to intermittent occlusion of the tracheostomy was 26.9 days (range 4–406 
days), and the average time to tracheostomy closure was 86.3 days (range 29–489 days). 
In our protocol, progressive closure of the tracheostomy is preferred, and occurs 
spontaneously in the majority of patients following occlusion. For patients, especially in the 
first weeks after discharge, this leads to a sensation of greater safety concerning minor 
episodes of food inhalation, which are relatively frequent. When the tracheostomy has 
almost closed, minor plastic surgery can then be performed. 
DISCUSSION 
The current trend for management of laryngeal cancer indicates that pursuing therapeutic 
options able to preserve laryngeal functionality provides the best quality of life for 
patients.2, 7, 11, 16 To realize this goal, different approaches have been pursued, in terms of 
chemo-radiotherapy7 or surgical treatment.3, 9, 10 The former is able to spare laryngeal 
function and patient outcome appears satisfactory, nevertheless, loco-regional control is 
compromised during long-term follow-up.7, 24 On the other hand, demolitive surgery 
provides better control of disease, though incurring a higher percentage of laryngeal 
function impairment and late sequelae that hamper the patients’ quality of life.5 With the 
diffusion of supracricoid partial laryngectomies (SCPL), the advent of supratracheal partial 
laryngectomies (STPL), and the consolidated role of conventional non-surgical organ 
sparing protocols and endoscopic procedures, the role of total laryngectomy in the 
treatment of endolaryngeal neoplasms has decreased considerably. 
In this study, we have analyzed the outcomes of 115 patients affected by LSCC 
undergoing STPL, a novel laryngeal sparing surgery previously described by our group in 
2006.13 
Glottic tumors with sub-glottic extension (cT3 with vocal cord and arytenoid fixation) may 
be a problematic category to manage with supracricoid laryngectomy or chemo-radiation, 
inasmuch as they often result in early pT4a for extra-laryngeal extension. Indeed, the 
selected cohort of patients considered in our study was composed of a higher percentage 
of pT4a cases, despite the fact that the amount of supraglottic cancers was lower than in 
previously described trials. 
The 5-year OS in the present study was 79%, better than the ca. 60% observed for both 
concomitant chemoradiotherapy or induction chemotherapy and radiotherapy.5, 7, 25 These 
data were also confirmed for more advanced pT4a tumors that displayed a 5-year OS of 
74%. The DFS observed in our study overlapped with that already demonstrated by Wolf 
et al. using the demolitive surgical approach (about 70%). These data show that carefully 
selected patients can achieve good results even with an "extreme partial" surgical 
approach. However, the DFS for pT4a cancer (49%) was significantly lower than those for 
the other classifications considered (83% pT3, 86% pT2), but higher than those obtained 
by management with radiotherapy and/or chemotherapy (ranging from 26% to 38%, 
respectively).7, 24 As a consequence, the possibility to develop recurrences was reduced. 
In fact, the 2-year LRC was maintained in 79% of patients but decreased to 69% at 5 
years. Analyzing these data, we can observe that such a trend was due to pT4a tumors, 
whose 5-year LRC was only 51%. Nevertheless, it is comparable with the LRC detected by 
Forastiere and colleagues in concomitant Cisplatin/radiotherapy (Cisplatin/RT) 
management.7, 24 From this point of view, the total incidence of recurrences after STPL 
overlapped with that of total laryngectomy demonstrated by Wolf’s trial.5 In the present 
series, the proportion of patients subjected to total laryngectomy for either functional or 
oncological purposes, was significantly low (14.8%) and there was no perioperative 
mortality. 
Not surprisingly, the total amount of neck metastases (less than 10%) was lower than in 
previously reported statistics for demolitive surgery (17%) and demolitive surgery with 
concomitant chemoradiotherapy (12–22%). These interventions are normally considered in 
cN0 and cN1 patients, which represent the majority of glottic tumors, even in 
intermediate/advanced T classification. Finally, the 5-year LFP obtained by STPL was in 
line with that achievable with concomitant Cisplatin/RT. Maintenance of laryngeal function 
was critical in patients affected by pT4a cancer (59% at 5 years) and in those older than 
65 years (64% at 5 years). Although the function of the remaining larynx is problematic in 
some cases, both objective and subjective outcomes have demonstrated the quite 
satisfactory validity of STPLs in sparing laryngeal function, albeit at the obvious expense of 
a simplified laryngeal framework. This shows the impressive ability of this organ to recover 
the essentials of its function after partial surgical mutilation, provided that tissue has been 
sacrificed and the organ reconstructed according to functional criteria. Based on our 
experiences, STPLs can be tailored to each patient, depending on the extent of the lesion. 
This is possible since the larynx tolerates tumor-free margins of only 4–5 mm. Therefore, 
the radicality of surgery should always be routinely checked intra-operatively by frozen 
sections. 
Nevertheless, persistent slight dysphagia and aspiration pneumonia still represent major 
complications in patients undergoing STPLs, while voice was significantly deteriorated, 
and generally quite hoarse and breathy.26 
In elderly patients (13 patients aged >70 years), cricoarytenoid joint resection had a clear 
impact, with worsening swallowing recovery: five out of 11 cases of AP occurred in elderly 
patients, in whom gastrostomy was maintained in one patient owing to repeated episodes 
of AP, and one was subjected to total laryngectomy. Anyway, high-grade dysphagia and 
aspiration pneumonia occurred rarely in patients undergoing STPLs if compared with 
others type of surgical technique, affecting physical and emotional condition of these 
patients. 
In conclusion, our results demonstrate that, in the case of glottic tumors with sub-glottic 
extension, the choice of STPL versus chemo-radiation protocols can be considered to be 
viable not only in prognostic terms, but also in terms of functional results such as a 
reduction in the number of total laryngectomies. This option must be aimed at carefully 
selected patients with a strong desire to avoid total laryngectomy and suffering from LSCC 
in well-defined intermediate/advanced stages, often early pT4a for extralaryngeal 
extension. The gold standard indication is glottic cT3 with vocal cord and arytenoid fixation 
and sub-glottic extension: the option of a supracricoid partial laryngectomy is very much at 
risk of leaving positive margins as the section line passes through a cricoarytenoid joint. 
Nevertheless, even in these cases, it is possible to obtain good oncological and functional 
results, even with an “extreme partial” surgical approach. The selection of patients must be 
made very carefully because, at the end of the work-up, the surgeon should be able to 
ensure safe margins with sufficient certainty thus avoiding an upfront total laryngectomy. 
When the tumor clearly extends beyond the limits of the larynx, both the severity of the 
intervention and the necessity for adjuvant radiotherapy demand that extreme caution be 
taken when considering the indications. 
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Figure legends 
Fig. 1. End point analysis (overall survival, disease-free survival and loco-regional control) 
of the patient cohort using Kaplan–Meier curves. 
 
Fig. 2. Patient cohort stratification for lesion classification (left column), previous treatment 
(middle column) and age (right column) using Kaplan–Meier curves. The end points 
considered were overall survival (top row), disease-free survival (middle row) and loco-
regional control (bottom row). Statistically significant differences were seen for patients 
affected by pT4a tumors in terms of both disease-free survival and loco-regional control. * 
= p< 0.05; ** = p< 0.01 
 Fig. 3. Evaluation of laryngeal function preservation in the patient cohort stratified for 
lesion classification (left column), previous treatment (middle column) and age (right 
column) using Kaplan–Meier curves. Statistically significant impairments were seen in 
patients affected by pT4a tumors or in those older than 65. ** = p< 0.01. 
 
 
